当前位置: 首页 > 期刊 > 《健康大视野·医学分册》 > 202016
编号:13819619
米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤的临床疗效分析
http://www.100md.com 2020年8月15日 《健康大视野》 202016
     【摘 要】目的:观察米非司酮联合桂枝茯苓胶囊对子宫肌瘤疗效。方法:2018年1-12月166例子宫肌瘤患者,随机分实验组、对比组,实验组加用桂枝茯苓胶囊,对比组米非司酮治疗,比较效果。结果:实验组不良反应发病率、总有效率明显优于对比组(P<0.05).结论:子宫肌瘤在米非司酮治疗基础上,应用桂枝茯苓胶囊治疗效果更高。

    【关键词】子宫肌瘤;米非司酮;桂枝茯苓胶囊

    Abstract:Objective To observe the curative effect of mifepristone combined with Guizhi Fuling Capsule on hysteromyoma. Methods: from January to December 2018, 166 cases of hysteromyoma were randomly divided into experimental group and control group. The experimental group was treated with Guizhi Fuling Capsule and the control group was treated with mifepristone. Results: the incidence rate and the total effective rate of the experimental group were significantly better than those of the contrast group (P < 0.05). Conclusion: the treatment of uterine fibroids with mifepristone on the basis of Guizhi Fuling Capsule has higher effect.

    Key words: hysteromyoma; mifepristone; Guizhi Fuling Capsule

    我国的子宫肌瘤高发年龄30-50岁 ......

您现在查看是摘要页,全文长 3710 字符